Found: 34
Select item for more details and to access through your institution.
Eliciting judgements about dependent quantities of interest: The SHeffield ELicitation Framework extension and copula methods illustrated using an asthma case study.
- Published in:
- Pharmaceutical Statistics, 2022, v. 21, n. 5, p. 1005, doi. 10.1002/pst.2212
- By:
- Publication type:
- Article
Improving the assessment of the probability of success in late stage drug development.
- Published in:
- Pharmaceutical Statistics, 2022, v. 21, n. 2, p. 439, doi. 10.1002/pst.2179
- By:
- Publication type:
- Article
Response to comments on Jaki et al., A proposal for a new PhD level curriculum on quantitative methods for drug development. Pharm Stat 17(5):593‐606, Sep/Oct 2018., DOI:https://doi.org/10.1002/pst.1873
- Published in:
- Pharmaceutical Statistics, 2019, v. 18, n. 3, p. 284, doi. 10.1002/pst.1942
- By:
- Publication type:
- Article
Designing and evaluating dose-escalation studies made easy: The MoDEsT web app.
- Published in:
- Clinical Trials, 2020, v. 17, n. 2, p. 147, doi. 10.1177/1740774519890146
- By:
- Publication type:
- Article
Bayesian survival analysis in clinical trials: What methods are used in practice?
- Published in:
- Clinical Trials, 2017, v. 14, n. 1, p. 78, doi. 10.1177/1740774516673362
- By:
- Publication type:
- Article
Assurance methods for designing a clinical trial with a delayed treatment effect.
- Published in:
- Statistics in Medicine, 2024, v. 43, n. 19, p. 3595, doi. 10.1002/sim.10136
- By:
- Publication type:
- Article
Group sequential tests for delayed responses (with discussion).
- Published in:
- Journal of the Royal Statistical Society: Series B (Statistical Methodology), 2013, v. 75, n. 1, p. 3, doi. 10.1111/j.1467-9868.2012.01030.x
- By:
- Publication type:
- Article
A quantitative framework to inform extrapolation decisions in children.
- Published in:
- Journal of the Royal Statistical Society: Series A (Statistics in Society), 2020, v. 183, n. 2, p. 515, doi. 10.1111/rssa.12532
- By:
- Publication type:
- Article
Correction to: Choosing the target difference and undertaking and reporting the sample size calculation for a randomised controlled trial - the development of the DELTA2 guidance.
- Published in:
- 2019
- By:
- Publication type:
- corrected article
DELTA<sup>2</sup> guidance on choosing the target difference and undertaking and reporting the sample size calculation for a randomised controlled trial.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Choosing the target difference and undertaking and reporting the sample size calculation for a randomised controlled trial - the development of the DELTA<sup>2</sup> guidance.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Mycophenolate Mofetil Versus Cyclophosphamide for Remission Induction in Childhood Polyarteritis Nodosa: An Open‐Label, Randomized, Bayesian Noninferiority Trial.
- Published in:
- Arthritis & Rheumatology, 2021, v. 73, n. 9, p. 1673, doi. 10.1002/art.41730
- By:
- Publication type:
- Article
Incorporating individual historical controls and aggregate treatment effect estimates into a Bayesian survival trial: a simulation study.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Study to evaluate the optimal dose of remifentanil required to ensure apnea during magnetic resonance imaging of the heart under general anesthesia.
- Published in:
- Pediatric Anesthesia, 2021, v. 31, n. 5, p. 548, doi. 10.1111/pan.14164
- By:
- Publication type:
- Article
Asymmetric inner wedge group sequential tests with applications to verifying whether effective drug concentrations are similar in adults and children.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Designing multi-arm multi-stage clinical trials using a risk-benefit criterion for treatment selection.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Optimizing the data combination rule for seamless phase II/III clinical trials.
- Published in:
- 2015
- By:
- Publication type:
- journal article
Optimizing the data combination rule for seamless phase II/III clinical trials.
- Published in:
- Statistics in Medicine, 2015, v. 34, n. 1, p. 39, doi. 10.1002/sim.6316
- By:
- Publication type:
- Article
Bayesian methods for the design and interpretation of clinical trials in very rare diseases.
- Published in:
- Statistics in Medicine, 2014, v. 33, n. 24, p. 4186, doi. 10.1002/sim.6225
- By:
- Publication type:
- Article
Incorporating prognostic factors into causal estimators: A comparison of methods for randomised controlled trials with a time-to-event outcome.
- Published in:
- Statistics in Medicine, 2012, v. 31, n. 26, p. 3073, doi. 10.1002/sim.5411
- By:
- Publication type:
- Article
Bridging the gap: a review of dose investigations in paediatric investigation plans.
- Published in:
- British Journal of Clinical Pharmacology, 2014, v. 78, n. 4, p. 898, doi. 10.1111/bcp.12402
- By:
- Publication type:
- Article
Many-to-one comparisons after safety selection in multi-arm clinical trials.
- Published in:
- PLoS ONE, 2017, v. 12, n. 6, p. 1, doi. 10.1371/journal.pone.0180131
- By:
- Publication type:
- Article
Choosing the target difference ('effect size') for a randomised controlled trial - DELTA<sup>2</sup> guidance protocol.
- Published in:
- 2017
- By:
- Publication type:
- journal article
A New Comprehensive Approach to Assess the Probability of Success of Development Programs Before Pivotal Trials.
- Published in:
- Clinical Pharmacology & Therapeutics, 2022, v. 111, n. 5, p. 1050, doi. 10.1002/cpt.2488
- By:
- Publication type:
- Article
A Bayesian decision‐theoretic approach to incorporate preclinical information into phase I oncology trials.
- Published in:
- Biometrical Journal, 2020, v. 62, n. 6, p. 1408, doi. 10.1002/bimj.201900161
- By:
- Publication type:
- Article
Clinical Drug Development in Epilepsy Revisited: A Proposal for a New Paradigm Streamlined Using Extrapolation.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Bridging across patient subgroups in phase I oncology trials that incorporate animal data.
- Published in:
- Statistical Methods in Medical Research, 2021, v. 30, n. 4, p. 1057, doi. 10.1177/0962280220986580
- By:
- Publication type:
- Article
Exposure-response modelling approaches for determining optimal dosing rules in children.
- Published in:
- 2020
- By:
- Publication type:
- journal article
A robust Bayesian meta-analytic approach to incorporate animal data into phase I oncology trials.
- Published in:
- 2020
- By:
- Publication type:
- journal article
A framework for prospectively defining progression rules for internal pilot studies monitoring recruitment.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Extrapolation of efficacy and other data to support the development of new medicines for children: A systematic review of methods.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Adaptive designs in clinical trials: why use them, and how to run and report them.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Elicitation of Expert Prior Opinion: Application to the MYPAN Trial in Childhood Polyarteritis Nodosa.
- Published in:
- PLoS ONE, 2015, v. 10, n. 3, p. 1, doi. 10.1371/journal.pone.0120981
- By:
- Publication type:
- Article
A phase I trial of the γ-secretase inhibitor MK-0752 in combination with gemcitabine in patients with pancreatic ductal adenocarcinoma.
- Published in:
- 2018
- By:
- Publication type:
- journal article